| 5DYY | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 5HH, CL, CSO, EDO, FUC, FUL, GOL, NAG | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Development of an in-vivo active reversible butyrylcholinesterase inhibitor., Kosak U, Brus B, Knez D, Sink R, Zakelj S, Trontelj J, Pislar A, Slenc J, Gobec M, Zivin M, Tratnjek L, Perse M, Salat K, Podkowa A, Filipek B, Nachon F, Brazzolotto X, Wieckowska A, Malawska B, Stojan J, Rascan IM, Kos J, Coquelle N, Colletier JP, Gobec S, Sci Rep. 2016 Dec 21;6:39495. doi: 10.1038/srep39495. PMID:28000737 | ||||||||||||||
| Data retrieval |
![]() |
| View 5DYY in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |